Seres Therapeutics Inc — Liquidità Trimestrale (NASDAQ:MCRB) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 139.81 M164.18 M143.8 M143.47 M138.19 M Totale passività 126.03 M113.72 M110.85 M99.78 M93.97 M Patrimonio netto totale 13.78 M50.47 M32.95 M43.7 M44.22 M Totale passività e patrimonio netto 139.81 M164.18 M143.8 M143.47 M138.19 M Debito totale 0———— Indebitamento netto -30.79 M————

Notizie

Seres Therapeutics fissa l’assemblea annuale 2026 per il 9 giugno

Seres Therapeutics schedules 2026 annual meeting for June 9

Seres Therapeutics, Inc. (MCRB) Discusses Leadership Transition, Strategic Direction and Microbiome Therapeutics Platform Prepared Remarks Transcript

Seres stock falls after pausing Phase 2 study and cutting workforce by 30%

Seres Therapeutics: Strong SER-155 Data, But Dilution Risk Now Warrants A 'Hold'

Seres Therapeutics publishes new insights on VOWST mechanism

3 Beaten-Down Biotech Stocks to Buy for a 2026 Turnaround

Oaktree Acquisition Corp. III Life Sciences nomina David A. Berry come direttore

Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director

Seres presenterà nuovi dati sullo studio delle infezioni del sangue SER-155

Seres to present new data on SER-155 bloodstream infection study

Seres Therapeutics annuncia riduzione del personale per estendere la liquidità